Microsoft word - arash mowla cv.doc

Curriculum Vitae
Arash Mowla , MD
(Last updated: August 15, 2010)
Sex: Male
Date of Birth: September, 1975
Place of Birth: Shiraz, Iran
Languages: Persian, English
Address: Department of Psychiatry, Bushehr University of Medical Sciences (BUMS), Bushehr,
Tel: +98-771-2532835, Fax: +98-771-2528587, Cell phone: +98-9173132001,
E-mail: mowlaar@gmail.com
Education:
(1996-2002) Medical School: School of Medicine, Shiraz University of Medical Sciences
(2004-2007) Residency in Psychiatry: Department of Psychiatry, Shiraz University of
(2005 ) Certification for completing a course of “Assessment and diagnosis of Neuropsychiatry
disorders”. A course offered by the State University of New York, 12th Nov 2004 -10th Jan 2005
(2007): Board certification in Psychiatry from Iranian board of Psychiatry
Current Position:
1) Assistant Professor, Department of Psychiatry, Fatemeh Zahra Hospital, Bushehr University of
Medical Sciences (BUMS), Bushehr, Iran (2007- ) 2) Consultant, Psychiatric Forensic committee, Bushehr Forensic organization, Bushehr, Iran
3) Editorial Board Member, the Open Neuropsychopharmacology Journal (2008- )
Awards and Honors:
2009: Awarded for “Outstanding presentation” by Ninth Annual Iranian Psychiatric Association,
2008: Awarded as “Senior Researcher” by Bushehr Province Governor for researches that
promote society health and medicine, Bushehr, Iran. 2007: Awarded for “Outstanding Thesis” for Degree of General Psychiatry in Shiraz University of
Medical Sciences (by Dean of Shiraz Medical School) 2006: Awarded as” Distinguished Researcher” by Vice Chancellor of research, Shiraz University
2006: Awarded as “First ranked resident” in department of psychiatry, Shiraz University of
Medical Sciences by Vice Chancellor of Education, Shiraz University of Medical Sciences 2003: Awarded as “Outstanding manager” for provision and education of health in Heleileh
2002: Awarded for the “Outstanding Thesis” for Degree of M.D in Shiraz Medical School (by
Publications:
1- Mowla A, Ghanizadeh A, Ashkani H: Diplopia with citalopram, A case Report. J Clin
Psychopharmacol. 2005 Dec; 25(6):623-4.
2- Mousavianasab M., Mowla A., Dehbozorgi G.: Obsessive Compulsive symptoms in middle school students and its association with Tic Disorder, Body Dimorphic Disorder and Trichotilomnia. Iran J Med Sci 2005; 30(4): 160-164.
3-Mowla A, Ghanizadeh A.: A comparison of effects of fluoxetine and nortriptyline on the symptoms of Major Depression Disorder. J Clin Psychopharmacol. 2006 Apr; 26(2):209-11
4- Pakseresht S, Mowla A, Ghanizadeh A.: Shared Psychotic disorder: A tragedy case report that
led to death of their daughter. Iran J Med Sci 2006; 31(2): 115-117.

5- Mowla A, Zandi T: Mini mental Status Examination: A screening instrument for cognitive and mood disorders of elderly Alzheimer Dis Assoc Disord. 2006 Apr-Jun; 20(2):124.
6-Mowla A, Ashkani H, Firoozabadi A, Ghanizadeh A, Chohedri H, Pani A, Gorman JM. Treatment of acute intractable traumatic pain by ECT, A case report. J Psychiatr Pract. 2007
Jan; 13 (1):55-7
7- Mowla A, Mosavinasab M., Pani A.: Study the effects of fluoxetine on the cognition of patients with mild cognitive impairments: a double –blind, placebo controlled, clinical trial. J Clin
Psychopharmacol. 2007 Feb;27(1):67-70.
8-Firoozabadi A , Mowla A ,Farashbandi H. Diphenoxylate dependency, A case report. Journal of
Psychiatric Practice. 2007 (13): 4-7
9- Sabayan B, Foroughinia F , Borhanihaghighi A , Mowla A. Are women with polycystic ovary
syndrome (PCOS) at higher risk for development of Alzheimer disease? Alzheimer Dis Assoc
Disord. 2007 July/September; 21(3):265-267
10- Mowla A, Mousavinasab M, Haghshenas H, Borhani haghighi A. Does Serotonin Augmentation have any Effect on Cognition and Activities of Daily Living in Alzheimer’s Dementia? A Double-Blind Placebo-Controlled Clinical Trial. J Clin Psychopharmacol. 2007
Oct; 27(5):484-487
11- Mowla A, Firoozabadi A, Borhani haghighi A, Sahraian A .Megadose Clonazepam Dependence: A case Report. J Clin Psychopharmacol. 2007 Oct; 27(5):542-543.
12- Sabayan B, Foroughinia F , Mowla A, Borhani haghighi A. Role of insulin metabolism disturbances in development of Alzheimer disease: Mini Review. Am J Alzheimer’s Dis Other
Demen. 2008 Apr-May; 23(2):192-9. Review.
13- Mowla A. Kianpor M, Bahtoee M, Sabayan B, Chohedri AH. .Comparison of clinical and demographic characteristics of Opium induced depression with Major Depressive Disorder. Am J
Drug Alcohol Abuse. 2008; 34(4):415-21.
14- Mowla A, Ashkani H, Ghanizadeh A, Gholam Reza Dehbozorgi. Do subjective memory complaints represent objective memory impairments in patients with major depressive disorder? Depress Anxiety. 2008; 25 (10):E92-6.
15- Mowla A, Namazi MR. Could Sertraline Afford Protection against Atherosclerosis? A Medical Hypothesis. South Med Journal. 2008; Sep 9.
16- Sabayan B, Namazi MR, Mowla A, Moniri SA. Are Patients with Darier and Haily-Haily Diseases Susceptible to Alzheimer’s disease? A Theory Based on Abnormal Intraneuronal Ca2+ Homeostasis. J Alzheimers Dis 2009 Mar;16(3):521-3. Review
17- Mowla A., Khosravizadegan F Ebrahimi A. Citalopram Associated with Complex Visual Hallucination. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):575-6. Epub
2009 Feb 1.
18-Mowla A, Asadipoya K. Delusional Parasitosis Associated with Heroin Withdrawal, A Case Report.Am J Addict. 2009 Jul-Aug; 18(4):334-5
19- Dastgheib SA, Mowla A, Ghanizadeh A, Khajeian AM. Does Electroconvulsive therapy afford protection against Olanzapine induced Parkinsonism? A Case Report. J ECT. 2009 Jun;
25(2):146.
20- Mowla A, Dastgheib SA, Ebrahimi AA, Pani A. Nasal Bleeding Associated with Fluoxetine and Risperidone Interaction; A Case Report. Pharmacopsychiatry. 2009 Sep; 42(5):204-5. Epub 2009
21- Mowla A, Pani A. Comparison of Topiramate with Risperidone for treatment of Behavioral Disturbances of Patients with Alzheimer’s disease: A Double-Blind Randomized Clinical Trial. J
Clin Psychopharmacol. 2010 Feb; 30(1):40-3.
22-Mowla A. Topiramate for Bruxism, Report of Two Cases . J Clin Psychopharmacol. 2010
Jun;30(3):346-7
23- Mowla A, Khajeian AM, Sahraian A. Does Topiramate Augmentation Have Any Effect on Obsessions and Compulsions of Patients with Resistant Obsessive-Compulsive Disorder? A Double-Blind Placebo-Control Clinical Trial (Accepted for publication by Journal of CNS
Spectrum)
24-Sabayan B, Farshchi B, Zamiri N, Sabayan B, Mowla A. Can Tetrathiomolybdate be a Potential Agent against Alzheimer’s disease? A Hypothesis Based on Abnormal Copper Homeostasis in Brain (Accepted for publication by Journal of J Alzheimer’s disease).
25-Mowla A, Kalantar M, Khazraei S. Comparison of Clinical Characteristics of Hypothyroid Induced Depression with Major Depressive Disorder ( Accepted for Publication by Journal
psychiatry Practice).
26-Mowla A, Sabayan B, Kardeh E. Topiramate Augmentation in patients with Resistant Major Depressive Disorder; A Double Blind Placebo Control Clinical Trial ( Under review by Journal of 27-Mowla A. Topiramate for Tic Disorder, A case Report (under review by Prog 28- Dastgheib SA, Ashkani H, Dehbozorgi G, Mowla A. Is ECT, TCAs or SSRIs Different in Reducing Suicidal Intent of Depressive Patients in Acute Phase Treatment? A Randomized Clinical Trial.2008 (Under review by the Journal of Psychiatric Practice) 29- Mowla A., Namazi M.R. Do Selective Serotonin Reuptake Inhibitors Cause Sleep Circadian Rhythm Disturbance by Reducing Melatonin? (Under review by the Journal of Sleep) 30- Mowla A. Depersonalization Symptoms Induced by Citalopram, a Case Report. (Under review by International Journal of Psychopharmacology) Presentations:
1. Mowla A. Adolescence Psychiatry. 1st National Congress of adolescence health. Bushehr, Iran.
2. Mowla A. Does topiramate augmentation have any effect on obsessions and compulsions of
patiants with Obsessive-Compulsive Disorder? A Double-Blind Placebo-Controlled Clinical Trial. 9th Annual Meeting of Iranian Psychiatric Association. Tehran, Iran. Dec 2009.
3. Mowla A., Mosavinasab M.,Haghshenas H.,Borhanihaghighi A. Does Serotonin
Augmentation have any Effect on Cognition and Activities of Daily Living in Alzheimer’s Dementia? A Double-Blind Placebo-Controlled Clinical Trial. IPA 2007 Osaka Silver Congress,
4. Mowla A., Mosavinasab M., Pani A.: Study the effects of Fluoxetine on the cognition of patients
with mild cognitive impairments: a double –blind, placebo controlled, clinical trial. 2ed
Mediterranean Congress of Neuroscience (supported by IBRO), Marrakech, Morocco,
5. Mowla A., Mosavinasab M., Pani A.: Study the effects of Fluoxetine on the cognition of patients
with mild cognitive impairments: a double –blind, placebo controlled, clinical trial. 10th Iranian
Pharmaceutical Sciences Conference (IPSC2006) Tehran, Iran, August 21-24, 2006.
6. Mowla A., Mowla A Mosavinasab M., Dehbozorgi G. Obsessive Compulsive symptoms in
middle school students and its association with Tic Disorder, Body Dimorphic Disorder and Trichotilomnia. 29th Annual Meeting of the Japan Neuroscience Society. Japan, July 19-21,
7. Mowla A., Ghanizadeh A. A comparison of effects of Fluoxetine and Nortriptyline on the
symptoms of Major Depression Disorder. International Neuroscience Conference (supported by
IBRO) Al-Ain, United Arab Emirates, 26-29 November, 2005.
Current Researches:
1-Comparison of Gabapentine with Risperidone for treatment of Behavioral Disturbances of Patients with Alzheimer’s disease: A Double-Blind Randomized Clinical Trial 2- Comparing the psychiatry symptoms in Alzheimer patients’ caregivers with schizophrenia 3-Study the prevalence and diagnosis of patients that attempt suicide in Bushehr 4- Comparing clinical characteristics of hyperthyroid induced anxiety with General Anxiety Review For:
Clinical Interventions in Aging

Journal of Opioid Management
Alzheimer Disease &Associated Disorders - An International Journal
1- Fisrt author in translation of “Conquering depression: a guide to understanding symptoms, causes and treatment of depressive illness” by Anthony Levitt to Persian. Nim Negah Publication. Shiraz, 2- Fisrt author in translation of “The only EKG book you will ever need”, 3rd edition, by Malcolm ISBN: 964-5855-47-0. [Now is in its 4th edition] 3- Coauthor in translation of “Developing Assertiveness” by Anni Townend to Persion. Astan Ghods Razavi Publication. Mashhad, Iran .2000 ISBN: 964-333-014-1 Certifications and Special Trainings:
2006: Certification for “Research in Pharmaceutical Sciences” offered by Iranian Association
of Pharmaceutical Scientists, August 21-24, 2006

2006: “International English Language Testing, (IELTS)” certification with overall Band Score
of 6.5 held By The British Council in Tehran, Iran
2006: Certification for completing a course of “Introductory on Dissociation & Trauma” offered
by The International Study of Dissociation. April 15-18, 2006
2004: Certification for completing a course of “Writing papers in medical fields workshop”, held
by Vice-chancellor for Research and Technology, Shiraz University of Medical Sciences, 2003: Certification for completing a course of “Tallasemia and its Management”, held by Vice-
chancellor for Research, Bushehr University of Medical Sciences, Busheher, Iran. 2003: Certification for completing a course of “Mental Health”, held by Vice-chancellor for
Research, Bushehr University of Medical Sciences, Busheher, Iran. 2003: Certification for completing a course of “Management of Pediatric Diseases”, held by Vice-
chancellor for Education, Bushehr University of Medical Sciences, Busheher, Iran. 2002: Certification for completing a course of “Breastfeeding and its benefits”, held by Vice-
chancellor for Education, Bushehr University of Medical Sciences, Busheher, Iran. 2001: “Basic life support workshop”, held by Department of Anesthesiology, SUMS, Shiraz, Iran.
1998: Certification for completing a course of “Diagnosis and Management of Diarrhea ”, held
by Vice-chancellor for Hygine, Shiraz University of Medical Sciences, Shiraz, Iran. 1993: Certification of “Senior Proficiency in English” Offered by Iran Language Institute. Shiraz,
Pervious Scientific and Social Activities:

2007: Scientific Referee of the First Iranian international Student Congress on Medical Research
and the Eight Iranian Annual Research Congress on Medical Sciences in Shiraz, Iran on may 23-25,

2007.
2005-2006: Editor of Iranian Journal of Medical Sciences (A General Medical Quarterly
published by SUMS, eISBN: 1735-3688, indexed in EMBASE / Excerpta Medica and Index
Medicus for WHO Eastern Mediterranean Region).
2006: Cooperation with Dr. Reddy Laboratories, Inc to prepare a complete report regarding
Citalopram side effects to be submitted to US Food and Drug Administration (FDA).

2004-2005: Instructor of English at Shiraz University Language Institute.

1999-2002: Member of editorial board of DARD monthly, a journal for increasing medical
information of general population in Iran published by Teimourzadeh publishing Co, Tehran, Iran.

2000-2001: Scientific Editor of Iranian Student News Agency (ISNA), Fars Province Division.

1992-1996: Volunteer member of Iran’s Red Crescent Society for peace and friendship, Shiraz,
Iran.

HOBBIES & INTERESTS:

Historical Books, Music, Swimming

LANGUAGES:

Persian, English, French (beginner), Arabic (beginner)


REFERENCES:

Source: http://med.bpums.ac.ir/UploadedFiles/userFiles/Arash_Mowla_CV__51f5062c.pdf